Ocugen Inc (OCGN) Stock Analysis

Ocugen Inc (OCGN) is a publicly traded company in the HEALTHCARE sector. It trades at $1.34, carries a market capitalization of $463.77M. This page summarizes the public market data, fundamentals, and frequently asked questions for OCGN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.34
• Market Cap: $463.77M
• EPS: $-0.24
• 52-Week High: $2.73
• 52-Week Low: $0.86

Market Sentiment

Ocugen Inc currently has a Neutral sentiment score of 0.04.

About Ocugen Inc

Ocugen, Inc. is an innovative clinical-stage biopharmaceutical company focused on developing transformative gene therapies aimed at curing various forms of blindness. Based in Malvern, Pennsylvania, the company leverages its proprietary technologies and strategic partnerships to advance its therapeutic pipeline, which includes treatments for retinal diseases. With a commitment to addressing unmet medical needs in ocular health, Ocugen is poised to make significant contributions to the field o...

GNG Research Analysis

GNG Research scores Ocugen Inc (OCGN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for OCGN.

Frequently Asked Questions

Does OCGN pay dividends?

Ocugen Inc (OCGN) does not currently pay a regular dividend.

What is OCGN's market cap?

Ocugen Inc (OCGN) has a market capitalization of $463.77M with a current stock price of $1.34.